Abstract

Donate to Lymphatic Education & Research Network's Annual Appeal
There is no better time to support the fight against lymphatic diseases such as lymphedema, lipedema, and lymphatic anomalies. This year, a generous family impacted by lymphatic disease is pledging a dollar-for-dollar match, up to $83,000 through year end. Every $25 becomes $50; $50 becomes $100; and $100 becomes $200. With your support, we can change the future for all those who live with lymphatic diseases.
World Lymphedema Day 2023
World Lymphedema Day is March 6, and the purpose of the day is to raise worldwide awareness of lymphatic diseases. Each year we make a promotional video with an introduction from Lymphatic Education & Research Network (LE&RN) spokesperson Kathy Bates, followed by lymphatic disease advocates in as many countries as we can represent. If you live outside of the United States, we would love to include you in the 2023 video! Just visit https://lymphaticnetwork.org/wld for details.
LE&RN's Centers for Disease Control and Prevention Grant Is Hard at Work
Television stations across the country are getting the seven public service announcements created as part of LE&RN's National Awareness Campaign for Cancer-Related Lymphedema. This project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award with 100% funded by CDC/HHS. For more information please visit https://lymphaticnetwork.org/learn-live.
2022 LE&RN Lymphatic Summit
Lymphatic Disease: The clinician/patient interface in state-of-the-art diagnosis and management was presented online in its entirety on Friday, September 30, 2022. This year's summit highlighted state-of-the-art clinical management techniques and the patient–user interface with both disease and its management, and will be available on the LE&RN website www.lymphaticnetwork.org/virtual-lymphatic-summit-2022.
Grants Available for Lymphatic Researchers
Thanks to lobbying efforts by LE&RN and its advocates, the Senate FY 2023 Appropriations bill includes “lymphatic diseases” and “lymphedema” as diseases eligible for research funding in its peer-reviewed medical research program (PRMRP) solicitations. We are working to make sure the final defense appropriations bill includes these two important topics on its list of eligible conditions for study and should know the outcome late in the calendar year. This will be the first time in the history of this program that grants will be available to lymphatic researchers. Additional information about the two-tier review process is available at https://cdmrp.health.mil/about/2tierRevProcess.aspx.
William Repicci
President and CEO
Lymphatic Education & Research Network (LE&RN)
